Elsevier

Life Sciences

Volume 55, Issue 1, 1994, Pages PL9-PL14
Life Sciences

Clozapine attenuates cocaine conditioned place preference

https://doi.org/10.1016/0024-3205(94)90084-1Get rights and content

Abstract

Clozapine, an atypical neuroleptic, has dopamine and serotonin antagonist actions that suggest its potential as a cocaine abuse pharmacotherapy. Yet, self-administration and discriminative stimulus studies in animals have reported both an enhancement and a partial blockade of cocaine's behavioral effects with clozapine. The present study examines further the effects of clozapine on cocaine conditioned place preference. Clozapine (10 mg/kg, s.c.) treatment significantly attenuated the development of cocaine (10mg/kg, i.p.) conditioned place preference. These results, coupled with research that shows clozapine has limited extrapyramidal side effects, suggest that it should be considered as a pharmacotherapy for cocaine abuse.

References (23)

  • S.B. Ross et al.

    Eur. J. Pharmacol.

    (1969)
  • H. Canton et al.

    Eur. J. Pharmacol.

    (1990)
  • E.A. Loh et al.

    Pharmacol. Biochem. Behav.

    (1992)
  • T.A. Kosten et al.

    Life Sci.

    (1991)
  • E.B. Nielsen et al.

    Eur. J. Pharmacol.

    (1985)
  • B.A. Ellenbroek et al.

    Eur. J. Pharmacol.

    (1991)
  • A.M. Murray et al.

    Eur. J. Pharmacol.

    (1990)
  • C.E. Johanson et al.

    Pharmacol. Rev.

    (1989)
  • M.C. Ritz et al.

    Science

    (1987)
  • G.F. Koob et al.

    Science

    (1988)
  • R.A. Wise et al.
  • Cited by (46)

    • Opposite regulation of conditioned place preference and intravenous drug self-administration in rodent models: Motivational and non-motivational examples

      2020, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      In contrast to typical neuroleptics like haloperidol that act through dopaminergic D2 receptors, the atypical neuroleptic clozapine has weak affinity for the D2 receptor in favor of serotonergic receptor antagonism, primarily the 5-HT2A subtype (Meltzer et al., 2012), as well as interaction with the GABAB receptor (Wu et al., 2011), thus producing a behavioral profile different from haloperidol. In rats, while clozapine pretreatment blocks the development of cocaine CPP (Kosten and Nestler 1994), it increases PR-SA for cocaine at moderate clozapine doses (Loh et al. 1992). In contrast to PR-SA, however, clozapine decreases cocaine FR-SA in rats, with no compensatory increase in intake that is typically observed with D2 antagonists such as haloperidol (Roberts and Vickers 1984).

    • An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF)

      2018, Schizophrenia Research
      Citation Excerpt :

      There has been limited research using clozapine in CPP. One study showed that clozapine attenuated cocaine CPP, but the dose of clozapine used (10 mg/kg) in that study was substantially higher than the dose used in the present study (Kosten and Nestler, 1994). With respect to the aversive dose of nicotine, NS-treated animals demonstrated a conditioned place aversion, whereas NQ-treated animals did not demonstrate an aversion to the high dose of nicotine.

    View all citing articles on Scopus
    View full text